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Expression of osteopontin in gentamicin-induced acute tubular including the kidney, lung, liver, bladder, pancreas, and
necrosis and its recovery process. breast [1–3]. Structurally, the OPN protein is roughly
Background. There is controversy regarding the exact local-
globular, contains an arginine-glycine-aspartic acid (RGD)ization and roles of osteopontin (OPN), a multipotential che-
sequence, and is highly phosphorylated on up to 28 serinemokine, in renal injury. There is little information on the ex-
pression and role of OPN in gentamicin-induced acute tubular residues [4].
necrosis (ATN) and its recovery process. Osteopontin is expressed in the normal kidney and
Methods. A severe ATN model was made using male Wistar
induced under various experimental pathological condi-rats by injecting gentamicin (150 mg/kg/day) for five days and
tions [5, 6], such as angiotensin II-induced tubulointer-limiting the provision of water. The expression and localization
of OPN mRNA and protein, ED1 as a macrophage marker, stitial nephritis [7], cyclosporine nephropathy [8], hydro-
proliferating cellular nuclear antigen (PCNA), CD44 as an nephrosis caused by unilateral ureteral ligation [9], renal
OPN receptor, megalin as a proximal tubule marker, and their
ischemia [10, 11], cisplantin nephropathy (abstract; Iguchirelationships to each other were examined from the early tubu-
et al, J Am Soc Nephrol 9:A3043, 1998), and crescenticlar necrotic period to the late recovery period by Northern
blotting, in situ hybridization, and double immunohistochemi- glomerulonephritis [12, 13]. Despite this, little is known
cal staining. about the expression of OPN in gentamicin-inducedResults. In the gentamicin group, OPN mRNA and protein
acute tubular necrosis (ATN) and its recovery process,were expressed in only the PCNA-positive proliferating corti-
cal distal tubules, not in the necrotic proximal tubules, until including regeneration of renal tubular epithelial cells
day 6 after the first administration, but were found markedly following ATN. In addition, the exact localization of
in PCNA-positive regenerative proximal and distal tubules on OPN in the kidney has been controversial because thedays 10, 15, and 30. The localization of PCNA-positive cells
discrimination between the proximal and distal tubuleswas almost always accompanied with the up-regulated expres-
sion of OPN using quantitative analysis (P , 0.01). CD44 becomes difficult in pathological conditions [14].
expression was markedly up-regulated in the renal cortical Despite the significant progress in understanding the
tubular epithelium from days 6 to 30. In the control group, no structure and topography of OPN, its functional roleexpression of OPN and CD44 in the cortical area was found
remains insufficiently understood [15]. Based on thethroughout the experimental period.
Conclusions. These results suggested that OPN is related to known activities of OPN in vitro and in vivo, there are
the proliferation and regeneration of tubular epithelial cells currently two hypotheses for its role in renal pathologies
after tubular damage.
and pathophysiologies [6]. One hypothesis is that OPN
is not only produced by macrophages and activated T
cells, but also modulates their activity, both in migratingOsteopontin (OPN) is a 44 kD secreted glycosylated
to sites of injury and in responding to the activatorsphosphoprotein. Originally isolated from bone, it has been
present at such sites [6]. Another attractive hypothesisshown to be expressed in a number of different tissues,
holds that in some settings, OPN may act as a cell survival
factor for renal cells [15–17]. Recently, studies on theKey words: acute renal failure, megalin, cell proliferation, regenera-
tion, macrophage, CD44. roles of OPN have focused on its renoprotective action
[15–17], including repair and regeneration following re-Received for publication March 29, 2000
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macrophages, and regeneration of renal tubular epithe- ing vector, introduced into E. coli super competent cells,
and a single colony of transfected cells was used to pre-lial cells during the recovery process [18, 19]. The rela-
tionship between these toxic pathological and patho- pare OPN cDNA.
The plasmid sample with the OPN cDNA was linear-physiological processes and OPN expression is not
understood. In this study, we used a severe ATN model ized by incubation at 378C with Nco I as an antisense
probe and Sal I as a sense probe, respectively. The linear-induced by gentamicin administration and dehydration
and examined the expression and localization of OPN ization of the plasmid was confirmed by running the sam-
ples on a 1% agarose gel. The linearized plasmid wasin cortical tubules by Northern blot analysis, in situ hy-
bridization, immunohistochemistry, and double staining extracted with phenol/chloroform and precipitated in
ethanol.with antimegalin antibodies as a proximal tubule marker.
Throughout the observation of the exact localization of The in vitro transcription of the cDNA was performed
using a DIG RNA labeling kit (SP6/T7; BoehringerOPN, ED-1 as a monocyte/macrophage marker, prolifer-
ating cellular nuclear antigen (PCNA), CD44 as an OPN Mannheim, Leverkusen, Germany). One microgram of
linearized plasmid was used as a template and incubatedreceptor, and their relationship to each other from the
early ATN period to the later recovery period, we tried with SP6 DNA-dependent RNA polymerase for two
hours to obtain an antisense probe. A T7 promoter wasto clarify OPN’s role in severe gentamicin-induced ATN
and its recovery process. used to produce a sense probe, which was used as a
negative control. The synthesized RNA probes were re-
covered by phenol/chloroform extraction and ethanol
METHODS
precipitation and then redissolved in 100 mL diethyl
Animal experiments pyrocarbonate H2O and 1 mL of an RNase inhibitor
(Wako, Osaka, Japan).Experiments were performed on 40 seven-week-old
male Wistar rats (Charles River Japan, Yokohama, Ja-
Northern blot analysispan), weighing between 230 to 270 g, that were divided
into two groups: a gentamicin group and a control group. After removal of the kidneys, renal tissues were frozen
in liquid nitrogen and stored at 2808C until analysis.The rats in the gentamicin group were given 150 mg/kg/
day of gentamicin sulfate solution (Sigma-Aldrich Co., After homogenization, the total RNA of the tissue sam-
ples was extracted using ISOGENe, following the manu-St. Louis, MO, USA) by subcutaneous injection in the
neck for five days, and the rats in the control group were facturer’s protocol (Nippon Gene, Tokyo, Japan). For
Northern blotting, 20 mg total RNA was loaded per lanegiven an equal volume of normal saline instead. All ani-
mals were fed a diet of standard laboratory chow and and electrophoresed on a 1.5% agarose gel containing
formaldehyde and transferred to a nylon membraneallowed free access to water, but were deprived of water
for 24 hours before the first gentamicin administration (Hybond-N1; Amersham, Arlington Heights, IL, USA).
In this study, the previously mentioned digoxigeninand for 12 hours a day during gentamicin administration.
Five rats in each group were sacrificed under ether (DIG)-labeled OPN cRNA probe (50 ng/mL) was used.
Hybridization was performed at 688C for 16 hours withanesthesia on days 6, 10, 15, and 30 after the first gentami-
cin injection, respectively. Blood was taken from the shaking according to the standard protocol. After hybrid-
ization, the filter was stringently washed and then incu-abdominal aorta for the assay of urea nitrogen and creati-
nine via urease ultraviolet absorption spectrophotometry bated at room temperature for 30 minutes in a buffer
with 0.1 mL/mL of polyclonal sheep anti-DIG Fab frag-and alkali picric acid method, respectively. The bilateral
kidneys of one rat were rapidly removed and bisected ments conjugated with alkaline phosphatase (Boehringer
Mannheim). The excessive antibodies were washed offfor Northern blot analysis. The other four rats were infused
with 4% paraformaldehyde from the abdominal aorta, with the buffer. A color reaction was performed by incu-
bating the filter with 0.1 mL/mL NBT/BCIP color-sub-and the kidneys were removed and bisected for histologic
and immunohistochemical examination and in situ hy- strate solution at room temperature for two hours.
bridization. All tissues were routinely processed, embed-
In situ hybridizationded in paraffin, and cut serially into 5 mm thick sections.
Renal tissues for in situ hybridization were fixed with
Probe preparation 4% paraformaldehyde in 0.01 mol/L phosphate-buffered
saline (PBS; pH 7.4), dehydrated in an ethanol series,To obtain rat OPN cDNA, two primers, OPN5 (59-TC
TGACGAATCTCACCATTC-39) and OPN3 (59-TCTT and embedded in paraffin under RNase-free conditions.
Serial 5 mm thick sections were cut. Details of in situCCTTACTCTTAGGGTCTA-39), were designed and syn-
thesized according to the rat OPN cDNA sequence to hybridization techniques used here were reported pre-
viously [20]. In this study, a DIG-labeled OPN cRNAamplify a 568 bp fragment. The PCR product was cloned
into a pGEM-T Easy (Promega, Madison, WI, USA) clon- probe (0.5 mg/mL) and an OPN sense probe as a negative
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control were used. The hybridization for OPN mRNA viously in this article. In immunohistochemical double
was performed at 528C for 16 hours. The alkaline phos- staining, the first immunohistochemical staining was per-
phatase-conjugated anti-DIG-antibody was reacted with formed with a DAB peroxidase substrate solution, which
the sections at 378C for 30 minutes, and a coloring reac- showed a brown color reaction, followed by washing in
tion with NBT/BCIP was performed at room tempera- PBS for 3 3 5 minutes and treatment for 10 minutes in
ture for 12 hours. The sections obtained from the cisplan- a microwave oven in a 0.01 mol/L citrate buffer (pH 6.0).
tin nephropathy model (abstract; Iguchi et al, J Am Soc Then the second immunohistochemical staining was per-
Nephrol 9:A3043, 1998) were used as a positive control. formed with a Fuchsin alkaline phosphatase substrate
solution, which showed a red color reaction.
Immunohistochemistry
Quantitative analysisImmunohistochemical staining was carried out on 5 mm
wax sections. The sections were first dewaxed and dehy- A point-counting method was employed to quantitate
drated. Then they were incubated with 0.6% H2O2 in the OPN mRNA and OPN protein-positive fractional
methanol for 30 minutes to eliminate endogenous perox- volume of renal cortical proximal (megalin-positive),
idase activity and were treated with normal goat serum nonproximal (megalin-negative), and total tubular epi-
(Chemicon, Temecula, CA, USA) at room temperature thelium on double-staining sections for OPN mRNA or
for 30 minutes. Subsequently, they were incubated at OPN protein and megalin, respectively [21]. In each field,
48C for 24 hours with primary antibodies, which included 121 points (intersections) were counted on a 1 cm2 eye-
the following: mouse monoclonal anti-OPN antibody piece graticule with 11 3 11 equidistant grid lines. Under
(1 mg/mL; ARP, Belmont, MA, USA), rabbit polyclonal high magnification (3400), 20 consecutive nonoverlap-
antimegalin antibody (5 mg/mL; kindly provided by Drs. ping fields per section, that is, a total of 2420 points of
Robert A. Orlando and Marilyn G. Farquhar of the the renal cortex in each kidney, were observed. The per-
University of California, San Diego, CA, USA), mouse centages of OPN-positive proximal, nonproximal, and
anti-ED1 antibody (10 mg/mL; Serotec, Oxford, UK), total tubules were calculated, while the points falling on
mouse monoclonal antiproliferating cell nuclear antigen glomeruli, Bowman’s capsules, or tubular lumens were
antibody (1:20; Dako, Glostrup, Denmark), and mouse excluded.
monoclonal anti-CD44 antibody (1:100; Pharmingen, The quantitations for ED1-positive cells and PCNA-
San Diego, CA, USA). The sections were incubated with positive cells were undertaken under high magnification
a secondary antibody, either goat anti-mouse IgG conju- (3400) in which 20 randomly selected cortical graticule
gated with the alkaline phosphatase or the peroxidase
fields per section were examined. The ED1-positive cells
or anti-rabbit IgG conjugated with the peroxidase at
located in the tubulointerstitial area, including renal tu-room temperature for 30 minutes. After washing with
bular lumens and the PCNA-positive cells located in thePBS, the sections were incubated with a Fuchsin alkaline
renal tubular epithelium, were counted, and the numbersphosphatase substrate solution (Dako, Carpinteria, CA,
were averaged for each field.USA) with an endogenous alkaline phosphatase inhibi-
The correlation analysis for OPN and PCNA was un-tor (Dako, USA), or a DAB peroxidase substrate solu-
dertaken on double-staining immunohistochemistry sec-tion (Nichirei, Tokyo, Japan). The cellular nuclei of the
tions for the OPN protein and PCNA.sections were counterstained with hematoxylin. The cis-
plantin nephropathy model sections (abstract; Iguchi et Statistical analysis
al, J Am Soc Nephrol 9:A3043, 1998) were used as a
Statistical analysis was performed using the statisti-positive control.
cal software StatView Version 5. A P value of less than
0.05 was considered significant. Data are expressed asDouble staining
mean 6 SD.Double staining was performed on the same tissue
section, which included a combination of in situ hybrid-
ization for OPN mRNA and immunohistochemistry for RESULTS
megalin as a proximal tubule marker, a combination of
Biochemical dataimmunohistochemistry for OPN protein and megalin, a
The level of blood urea nitrogen (BUN) and serumcombination of OPN protein and ED-1 as a monocyte/
creatinine (SCr) in the gentamicin group rats increasedmacrophage marker, and a combination of the OPN
significantly on day 6 after the first administration (P ,protein and PCNA as a cell proliferation or regeneration
0.01), reached its peak on day 10 (P , 0.05), and thenmarker. For the in situ hybridization and immunohisto-
gradually decreased and almost returned to normal bychemistry tests, the sections were washed in PBS for 3 3
day 30. Two rats in the gentamicin group died on days5 minutes after in situ hybridization, and then immuno-
histochemical staining was performed as described pre- 13 and 15, respectively (Table 1).
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Histologic changes during the experimental period (Fig. 3). OPN mRNA
expression was shown simultaneously in the renal tu-Periodic acid-Schiff (PAS) staining showed that renal
bules of the cisplantin nephropathy model as a positivetubular necrosis apparently developed on day 6 after the
control (figure not shown). The sense control for OPNfirst administration in the gentamicin group. Superficial
mRNA was negative (figure not shown).cortical tubules revealed severe degeneration or necrosis
The expression of the OPN protein was recognized asof epithelial cells. On day 10, there were lots of desqua-
a punctate distribution in the cortical tubular epitheliummated epithelial cell debris in the renal tubular lumens.
from days 6 to 30, with a peak on day 15 in the gentamicinMononuclear cells infiltrated interstitial lesions from the
group. In the control group, the expression of OPN pro-superficial cortex to the corticomedullary zone. New cel-
tein was not detected in the cortical tubules during thelular lines that were thought to be regenerative tubular
experimental period (figure not shown). The localizationepithelial cells appeared along the tubular basement
of the OPN protein was positive in the medullary tubulesmembranes. The regenerative tubular epithelial cells be-
in both groups from days 6 to 30, but its distribution incame larger, and the renal tubular epithelium became
the gentamicin group was wider than the control onthicker on day 15. On day 30, most of the cortical tubular
days 6, 10, and 15 except for day 30. Bowman’s capsulestructures almost returned to the normal architecture,
epithelial cells showed positive OPN protein expressionbut spotty infiltration of mononuclear cells, atrophy of
in only the gentamicin group (Fig. 4). OPN protein ex-renal tubules, and fibrosis of the interstitium remained.
pression was shown simultaneously in the renal tubulesThe control group showed no significant histologic
of the cisplantin nephropathy model as a positive controlchanges throughout the experimental period.
(figure not shown).Based on the immunohistochemical staining of mega-
Double staining of in situ hybridization for OPNlin and cellular nuclear staining, it was evident that the
mRNA and immunohistochemistry for the megalin pro-necrotic tubules were proximal tubules. The distal tu-
tein used as a proximal tubule marker clearly revealedbules showed some proliferation changes on day 6. The
that expression of OPN mRNA was present in only distalregenerative changes occurred mainly in the proximal
tubules, but not in the proximal tubules of the renal
tubules, but also in the distal tubules from day 10 to day
cortex during the ATN period on day 6 after the first
15. By combination with PAS staining, it was shown that administration. However, in the recovery period on days
focal atrophic tubules existed in both the proximal and 10, 15, 30, the expression of OPN mRNA was present
distal tubules on day 30 (Fig. 1). not only in the distal tubules, but also in the proximal
tubules showing regenerating changes in the renal cortex.Expression and localization of OPN mRNA
Double-staining immunohistochemistry for the OPNand protein
protein with megalin showed that the localization of the
Compared with the control group, Northern blot anal- OPN protein was coincident with that of OPN mRNA
ysis showed markedly up-regulated expression of OPN in the renal cortex (Fig. 5).
mRNA in the kidneys of the gentamicin group from days Quantitative analysis showed that the percentage of
6 to 30 (Fig. 2). OPN mRNA-positive tubules in the proximal (megalin-
In the gentamicin group, histologic localization of positive) tubules was highest on day 15 in the gentamicin
OPN mRNA was shown in the cortical tubules by in situ group, while that in the nonproximal (megalin-negative)
hybridization from the early ATN period on day 6 to tubules, for example, the distal tubules, was highest on
the later recovery period on day 30. OPN mRNA expres- day 10 (Fig. 6). The location and level of OPN protein
sion was most widely distributed on day 10 and day 15, expression was almost the same as that of OPN mRNA
and decreased on day 30 in the cortical region. In the in the renal cortical tubules (data not shown).
control group, OPN mRNA was not detected in the
Demonstration of ED1-positive cells andcortical region throughout the experimental period, ex-
the relationship between ED1 and OPNcept for a weak expression in the descending thin limb
of the loop of Henle (not shown). The expression of To examine the relationship between OPN and mono-
OPN mRNA in the gentamicin group was also positive cyte/macrophage infiltration, we performed immunohis-
in the medullary tubules from days 6 to 30 and was tochemistry for ED1 (a monocyte/macrophage marker)
stronger than that of the control. The OPN mRNA sig- and double staining for OPN and ED1. In the gentamicin
nals in the medulla were strongest on day 6 and then group, only a few ED1-positive cells were present in
decreased gradually and almost returned to normal on the cortical tubulointerstitium on day 6, but many were
day 30 in the gentamicin group. Intraglomerular expres- present in the cortical interstitium and within the tubular
sion of OPN mRNA was not detected in either group, lumens on days 10 and 15, with the most on day 10 after
and only parietal epithelial cells of Bowman’s capsule the first administration. On day 30, they were focally
present in an atrophic, thick tubular epithelium and itsshowed weak positive signals in the gentamicin group
Fig. 1. Renal histologic changes in gentami-
cin-induced acute tubular necrosis (ATN) and
recovery. (A–E and F–J ) Serial sections, re-
spectively. (A–E) PAS staining. (F–J) Immu-
nohistochemical staining of megalin (a proxi-
mal tubule marker, brown) and cellular nuclear
staining. (A and F) Normal cortical renal tu-
bules. Note that megalin is positive in only
the proximal tubules (arrow), but not in other
tubules (arrowhead, F). (B and G) ATN on
day 6 after the beginning of gentamicin injec-
tion (150 mg/kg/day 3 5). Note the flattened,
desquamated epithelium, denuded basement
membranes, and intraluminal cellular debris
(arrow, B). Tubular necrosis occurs only in
proximal tubules (arrow, G), and evidence of
proliferation in distal tubules is shown (arrow-
head, G) as compared with control (arrow-
head, F). (C) Recovering renal cortical tubules
on day 10. Renal tubules are lined by regener-
ating cells (arrow). Some tubules are filled
with amorphous debris, while others have
cleared. Mononuclear cells aggregate in the
renal interstitium (arrowhead). (D) Recov-
ering renal cortical tubules on day 15. The
renal tubular epithelium becomes thick, but
the microvilli are relatively short and simple
(arrow). (H and I) Regenerating changes oc-
cur not only in proximal tubules (arrow), but
also in distal tubules (arrowhead) on day 10
(H) and day 15 (I). (E) Cortical renal tubules
on day 30. Most of the cell structure is compa-
rable to controls, but a small focus of atrophic
tubules (arrow), interstitial fibrosis, and mono-
nuclear cells remained (arrowhead). (J) Focal
atrophic tubules also include proximal (arrow)
and distal tubules (arrowhead) on day 30.
Original magnification 3100.
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Fig. 2. Northern blot analysis in gentamicin-
induced ATN and recovery.
Fig. 3. Osteopontin (OPN) mRNA expression from in situ hybridization in renal cortical tubules treated by gentamicin. (A) Up-regulation of
OPN mRNA only in cortical tubules having no necrosis, but not in necrotic tubules on day 6 after the first gentamicin administration. (B and C )
Marked up-regulation of OPN mRNA in regenerative renal tubules on day 10 (B) and day 15 (C). (D) Up-regulation of OPN mRNA focally in
some areas of the renal cortex on day 30. Original magnification 3100.
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Fig. 4. Expression of the OPN protein with immunohistochemistry in renal cortical tubules treated by gentamicin. (A) Up-regulation of OPN
protein in cortical tubules having no necrosis, but not in necrotic tubules on day 6 after the first gentamicin administration. (B and C ) Marked
up-regulation of the OPN protein as a punctate distribution in regenerative renal tubules on day 10 (B) and day 15 (C). (D) Up-regulation of the
OPN protein in the focal area of renal tubular atrophy and interstitial fibrosis on day 30. Original magnification 3100.
peripheral interstitium (Figs. 7 and 8). No distinct macro- Demonstration of PCNA-positive cells and
colocalization of PCNA and OPNphage infiltration was found in the control group (not
shown). Double staining showed that the location of To clarify the relationship between OPN expression and
OPN expression had no distinct relationship with the site cellular proliferation/regeneration, we carried out immu-
of monocyte/macrophage accumulation in most areas of nohistochemistry for PCNA and double staining for OPN
the cortex, but in some areas of the cortex, the location and megalin, OPN and PCNA. There were few PCNA-
of OPN expression was almost coincident with the site positive cells in the rat kidneys of the control group. In
of monocyte/macrophage infiltration in the gentamicin contrast, in the gentamicin group, the PCNA-positive
cells were observed in great numbers in the distal tubulesgroup (Fig. 9).
Fig. 5. Localization of OPN mRNA and the
OPN protein in renal cortical tubules treated
by gentamicin. OPN mRNA (blue) is shown
by double staining of in situ hybridization for
OPN and immunohistochemistry for megalin
(a proximal tubule marker, brown; A–E ).
OPN protein (red) is shown by immunohisto-
chemical staining of OPN and megalin (F–J ).
A–E and F–J are serial sections, respectively.
(A and F) Normal renal tubules showing no
OPN mRNA or OPN protein. (B and G) Up-
regulation of OPN mRNA and the OPN pro-
tein in cortical distal tubules (arrow), but not
in necrotic proximal tubules on day 6 after
the first gentamicin administration. (C and H)
Marked up-regulation of OPN mRNA and the
OPN protein not only in cortical distal tubules
(arrow), but also in proximal tubules (arrow-
head) on day 10. (D, E, I, and J) Up-regulation
of OPN mRNA and the OPN protein mainly
in cortical proximal tubules (arrow), but also
in distal tubules on day 15 (D and I) and on
day 30 (E and J). Double staining showed that
the localization of the OPN protein was coinci-
dent with that of OPN mRNA in the renal
cortex (arrow). Original magnification 3100.
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Table 1. Blood urea nitrogen (BUN) and serum creatinine (SCr) levels in rats after gentamicin administration
BUN mg/dL SCr mg/dL
Group Day 6 Day 10 Day 15 Day 30 Day 6 Day 10 Day 15 Day 30
Gentamicin 112.78632.69a 229.416134.40a 44.80615.32 29.9867.63 3.1060.96a 5.6663.65b 0.6360.22b 0.4060.18
Control 22.9261.39 23.1663.78 21.1263.75 23.5262.89 0.2060.00 0.2060.00 0.2860.05 0.2060.06
Data are means 6 SD. Gentamicin group rats were given 150 mg/kg/day gentamicin sulfate solution for 5 days by subcutaneous injection. Control group rats
received an equal volume of normal saline instead.
a P , 0.01 compared with Control
b P , 0.05 compared with Control
in the deep cortex, corticomedulla, and medulla in the
acute proximal tubular necrotic period on day 6 and in
the proximal and distal tubules of the cortex, as well as
medullary tubules, in the recovery period on days 10,
15, and 30, with the most seen on day 10 after the first
administration (Figs. 10 and 11; double staining for OPN
and megalin not shown). The double staining for OPN
and PCNA showed that PCNA-positive cells were
mainly present in the tubular epithelium with up-regu-
lated expression of OPN (Fig. 12). The correlation analy-
sis showed that PCNA-positive tubular epithelial cells
were associated with the expression of OPN in the genta-
micin-induced ATN period and the following recovery
period (r 5 0.966, 0.913, 0.850, and 0.956 on days 6, 10,
15, and 30, respectively, P , 0.01).
Expression of CD44
The immunohistochemistry for CD44 showed that ex-
pression of CD44 was markedly up-regulated in the corti-
cal tubular epithelium and infiltrating cells in the cortical
interstitium and tubular lumens from the tubular necrotic
period on day 6 to the recovery period on days 10, 15,
and 30 after the first administration in the gentamicin
group. In the control group, no expression of CD44 in
the cortical tubular epithelium was found throughout the
experimental period (Fig. 13).
DISCUSSION
Osteopontin is a secreted glycoprotein that has broad
tissue distribution and diverse biological functions [3, 6].
Its kidney expression has been demonstrated in normal
and a number of renal injury models [5, 6]. There is one
report regarding the expression of OPN in a gentamicin-
induced acute renal failure model [22]. In that report,
rats were given subcutaneous injections of gentamicin
(40 mg/kg) daily for 10 days and were sacrificed for
analysis on the 10th day of gentamicin administration. In
the model, the serum creatinine and blood urea nitrogenFig. 6. Quantitative analysis of cortical tubular OPN mRNA expres-
sion in gentamicin-induced ATN and recovery. Quantitation was based levels revealed abnormal elevation from the eighth day.
on double-staining sections of in situ hybridization for OPN mRNA The expression of OPN mRNA was not enhanced inand immunohistochemistry for megalin as a proximal tubule marker
that mild model by Northern blot analysis or in situusing a point-counting method. (A) Proximal (megalin-positive) tu-
bules. (B) Cortical nonproximal (megalin-negative) tubules. (C ) Corti- hybridization. We successfully made a severe ATN model
cal total tubules. GM6, GM10, GM15, and GM30 show days 6, 10, 15,
by injecting a high dose of gentamicin (150 mg/kg/day)and 30 after the first administration in the gentamicin group, respec-
tively. *P , 0.01; #P , 0.05; NS, no significant difference. for five days and limiting the provision of water to the
Fig. 7. Demonstration of ED1-positive cells in gentamicin-induced ATN and recovery. (A) A few ED1-positive cells are present in the cortical
tubular epithelium and interstitium on day 6 after the first gentamicin administration. (B and C ) Many ED1-positive cells are present in the
cortical interstitium and within tubular lumens on day 10 (B) and day 15 (C). (D) Quite a few ED1-positive cells are focally present in some
tubular epithelia and interstitia on day 30. Original magnification 3100.
Fig. 8. Quantitative analysis of cortical ED1-positive cells in gentami-
cin-induced ATN and recovery. ED1-positive cells in the tubules, inter-
stitium, and tubular lumens of the renal cortex reached a peak on day
10. GM6, GM10, GM15, and GM30 show days 6, 10, 15, and 30 after
the first administration in the gentamicin group, respectively. *P , 0.01;
#P , 0.05.
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experimental rats. In this study, the up-regulated expres- ogy have been insufficiently understood. In most studies,
a correlation existed between the magnitude of OPNsion of OPN mRNA and protein was shown distinctly
by Northern blot analysis, in situ hybridization, and im- expression in areas of tubulointerstitial injury and infil-
tration with macrophages, suggesting that OPN couldmunohistochemistry in the renal cortex from days 6 to
30 after the first gentamicin administration. The OPN participate directly in renal macrophage infiltration in
vivo [35–37]. In OPN knockout mice, it was reportedmRNA levels of the whole kidney by Northern blot
analysis on day 30 in the gentamicin group were almost that the macrophage influx after unilateral ureteral ob-
struction was significantly reduced as compared with con-the same as the control, possibly because the OPN
mRNA signals in the medulla almost returned to normal trol mice (abstract; Ophascharoensuk et al, J Am Soc
Nephrol 8:A481, 1997). Further evidence that OPN mayand OPN expression was restricted only in the focal area
of the cortex on day 30. modulate macrophage function comes from wound-heal-
ing experiments done by Liaw et al, in which the in-Studies of histologic localization in the normal kidney
and sources of OPN have given conflicting results [14]. creased cell debris in the healed wounds in OPN-defi-
cient mice was thought to represent a reduction ofIn an early immunohistochemical study in the rat, OPN
was found only in the proximal tubules [23]. Because macrophage activity [38]. However, there are some op-
posing reports. For example, in the renal cortex of strep-immunostaining was observed in components of the vac-
uolar-lysosomal system, it was concluded that OPN was tozotocin-induced diabetic rats, increased levels of OPN
were not associated with accumulation of monocyte/mac-absorbed from the tubule fluid [14]. Subsequent studies
using both in situ hybridization and immunohistochemis- rophages as identified by a cell type-specific monoclonal
antibody ED1 [39]. In human crescentic glomerulone-try demonstrated OPN mRNA and protein expression
in only the distal tubular cells of the normal rat kidney phritis, the majority of strongly OPN-positive cells were
monocyte/macrophages in a number of crescents, but[24], whereas other investigators found that OPN was
expressed in the descending thin limb of the loop of interstitial monocyte/macrophages did not express OPN
[40]. In our current study, the location of OPN expressionHenle and in the papillary and pelvic epithelium of the
renal fornix in the normal rat kidney [25]. Under renal had no close relationship with the site of monocyte/mac-
rophage accumulation in most areas. Only in some areas,disease conditions, the OPN expression of some models,
such as renal stone formation, was found mainly in the the location of OPN expression was almost coincident
with the site of monocyte/macrophage infiltration in thedistal tubular cells [22], but that of other models, such
as ischemia-induced acute renal failure, was noted not gentamicin group, as shown in Figure 9. These contrasting
results suggest that OPN may work as a chemotactic pro-only in the distal tubular cells, but also in the proximal
tubular cells [5]. These different results may be mainly tein in certain areas and time phases, and additionally
may play other roles as a multifunctional chemokine indue to the different causes and regions of damage in
different disease models. On the other hand, they may other areas and time phases in renal injury and its re-
covery process.also be due to different investigators having different
opinions on the same renal tubule segment. In fact, it is Recently, OPN has emerged as an important growth
promoter of vascular smooth muscle cells and cardiacvery difficult to distinguish proximal tubules clearly from
the loop of Henle, distal tubules, and collecting ducts in fibroblasts [41, 42]. In the kidney, OPN has been shown
to play a role in the regeneration of renal proximal tu-some pathological conditions, as shown in Figure 1. In
this study, we confirmed the exact localization and source bule cells after acute severe hypoxic or ischemic injury
[43, 44]. In addition, OPN is up-regulated during theof OPN in renal cortical tubules using serial sections and
double staining of OPN mRNA and megalin, as well as repair process of glomerular injury in the anti-Thy-1
model of glomerulonephritis (abstract; Prols et al, J Amdouble staining of the OPN protein and megalin. Megalin
served as a renal proximal tubule marker because it is Soc Nephrol 7:A2585, 1996). Hypoxia stimulated the re-
lease of OPN, and anti-OPN antibodies completely pre-thought to exist only in proximal tubular and glomerular
epithelial cells, but not in distal tubules, the loop of vented hypoxia-induced proliferation in cultured mesan-
gial cells and LLC-PK1 tubular epithelial cells (abstract;Henle, or collecting ducts of the kidney [26–31]. Because
OPN mRNA and OPN protein were expressed in the Sahai et al, J Am Soc Nephrol 8:A1983, 1997, and J Am
Soc Nephrol 9:A2280, 1998). These results suggest thatsame region as renal cortical tubules, as shown in Fig-
ure 5, it was clear that the OPN protein of renal cortical OPN may mediate the proliferation of mesangial and
LLC-PK1 cells induced by hypoxia [45]. In our study,tubules resulted from renal cortex tubular epithelial cell
production, but not from resorption of renal tubular OPN mRNA and protein were only expressed in the
proliferating distal tubules of the rat kidney, but notfluid. Several in vitro studies have demonstrated that
cultured renal epithelial cells have the ability to secrete in necrotic proximal tubules in the gentamicin-induced
ATN period on day 6 after the first of administration,OPN [32–34].
The roles of OPN in renal pathology and pathophysiol- whereas during the recovery process on days 10, 15,
Fig. 9. Relationship between ED1 and OPN
in gentamicin-induced ATN and recovery.
Double staining for OPN (brown) and ED1
(red) show the location of OPN expression
had no distinct relationship with the site of
ED1-positive cell accumulation in some areas
of the cortex on day 10 (A) and day 15 (B and
C ). However, in some areas of the cortex on
day 30 (D), the location of OPN expression
was almost coincident with the site of ED1-
positive cell infiltration in the gentamicin
group. Original magnification 3100.
c
Fig. 10. Demonstration of proliferating cell nuclear antigen (PCNA)-positive cells in cortical tubules in gentamicin-induced ATN and recovery.
(A) There are very few PCNA-positive cells in normal cortical tubules. (B) The PCNA-positive cells are present in tubules having no necrosis on
day 6 after the first gentamicin administration (a lot of desquamated epithelial cell debris in the PCNA-positive tubular lumens can be seen). (C )
There are many PCNA-positive cells in the cortical tubules on day 10. The new regenerative cells show flat cellular nuclei. (D) The PCNA-positive
cellular nuclei become larger on day 15. (E ) PCNA-positive cells are focally present in the cortical tubules and interstitium on day 30. Original
magnification 3100.
Fig. 12. Colocalization of PCNA and OPN
in gentamicin-induced ATN and recovery.
Double staining for OPN (brown) and PCNA
(red) shows that the PCNA-positive cells are
mainly present in the tubular epithelium with
up-regulated expression of OPN on days 6
(A), 10 (B), 15 (C ), and 30 (D) after the first
gentamicin administration, although not all
cells in the OPN-positive area are PCNA-posi-
tive, especially on day 15 (C). Original magni-
fication 3100.
Fig. 11. Quantitative analysis of cortical tubular PCNA-positive cells in
gentamicin-induced ATN and recovery. The number of cortical tubular
PCNA-positive cells reached a peak on day 10, but there was no signifi-
cant difference compared with that on day 15. GM6, GM10, GM15,
and GM30 show days 6, 10, 15, and 30 after the first administration
in the gentamicin group, respectively. *P , 0.01. NS, no significant
difference.
Fig. 13. Expression of CD44 in gentamicin-induced ATN and recovery. Immunohistochemistry for CD44 shows CD44 staining is negative in the
cortical tubules in the control group (A), but CD44-positive staining is markedly present in the cortical tubular epithelium and infiltrating cells in
the cortical interstitium and tubular lumens on days 6 (B), 10 (C ), 15 (D), and 30 (E ) after the first administration in the gentamicin group.
Original magnification 3100.
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